Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Edwards Lifesciences Corporation

Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Reports First Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Reports Fourth Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Data Presented at TCT Reinforce Edwards Lifesciences’ Commitment to Structural Heart Innovation
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Reports Third Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Completes Sale of Critical Care
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Reports Second Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Acquire Innovalve
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Sell Critical Care to BD
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Reports First Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.